Curable (XKRX:086460) ROCE % : -42.17% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Curable ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Curable's annualized ROCE % for the quarter that ended in Dec. 2023 was -42.17%.

Curable ROCE % Historical Data

The historical data trend for Curable's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curable ROCE % Chart

Curable Annual Data

Trend

Dec21

Dec22

Dec23

ROCE %

-34.80

-6.21

-42.17

Curable Semi-Annual Data
	Dec21	Dec22	Dec23
ROCE %	-34.80	-6.21	-42.17

Curable ROCE % Calculation

Curable's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-7399.64	/	( ( (26407.727 - 6710.862)	+	(24905.358 - 9505.853) )	/ 2 )
	=	-7399.64	/	( (19696.865	+	15399.505)	/ 2 )
	=	-7399.64	/	17548.185
	=	-42.17 %

Curable's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Dec. 2022 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Dec. 2022 )		(Q: Dec. 2023 )
	=	-7399.64	/	( ( (26407.727 - 6710.862)	+	(24905.358 - 9505.853) )	/ 2 )
	=	-7399.64	/	( ( 19696.865	+	15399.505 )	/ 2 )
	=	-7399.64	/	17548.185
	=	-42.17 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2023) EBIT data.

Curable (XKRX:086460) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Curable ROCE % Related Terms

Thank you for viewing the detailed overview of Curable's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Curable (XKRX:086460) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Curable Inc (XKRX:086460) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

93, Dongtan-daero 23-gil, 10th Floor, Gyeonggi-do, Hwaseong-si, KOR

Website

http://www.snp-genetics.com

Curable Inc provides genome analysis service.

Curable (XKRX:086460) Headlines

No Headlines